Pharmacokinetics and Safety of WAL2014 (Talsaclidine) in Healthy Male Volunteers
Clinical trial NCT02264067 · COMPLETED
Trial details
- NCT number
- NCT02264067
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1998-07-01
- Primary completion
- 1998-11-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.